Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review
CT Supuran - Expert Opinion on Therapeutic Patents, 2019 - Taylor & Francis
Introduction: Macular degeneration (MD) and macular edema (ME) are ophthalmologic
diseases affecting an increasing number of the aging population. Until recently, there were …
diseases affecting an increasing number of the aging population. Until recently, there were …
Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review
CT Supuran - EXPERT OPINION ON THERAPEUTIC PATENTS, 2019 - flore.unifi.it
Introduction: Macular degeneration (MD) and macular edema (ME) are ophthalmologic
diseases affecting an increasing number of the aging population. Until recently, there were …
diseases affecting an increasing number of the aging population. Until recently, there were …
Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review
CT Supuran - Expert opinion on therapeutic patents, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction: Macular degeneration (MD) and macular edema (ME) are ophthalmologic
diseases affecting an increasing number of the aging population. Until recently, there were …
diseases affecting an increasing number of the aging population. Until recently, there were …
Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review.
CT Supuran - Expert Opinion on Therapeutic Patents, 2019 - europepmc.org
Introduction: Macular degeneration (MD) and macular edema (ME) are ophthalmologic
diseases affecting an increasing number of the aging population. Until recently, there were …
diseases affecting an increasing number of the aging population. Until recently, there were …